Report No: 521
Date: 11/16/2000

OMB COST ESTIMATE
FOR PAY-AS-YOU-GO CALCULATIONS

1. LAW NUMBER: P.L.106-354 (H.R. 4386)
2. BILL TITLE: Breast and Cervical Cancer Prevention and Treatment Act
3. BILL PURPOSE: Authorizes States to provide medicaid benefits to uninsured women who have been diagnosed with breast or cervical cancer through a certain Federally funded screening program.
4. OMB ESTIMATE: P.L. 106-354 gives States the option of providing medicaid coverage to certain women who have been diagnosed with breast or cervical cancer under the Center for Disease Control and Prevention's national breast and cervical cancer early detection program for low-income women. As an incentive for States to participate in this program, they will receive an enhanced Federal medicaid match rate for services provided to women who become eligible as a result of this Act. OMB estimates that P.L. 106-354 will increase Federal medicaid costs by $250 million over five years.

	(Fiscal years; in millions of dollars)
	2000	2001	2002	2003	2004	2005
Net costs...............	0	20	30	45	70	85

5. CBO ESTIMATE:

	(Fiscal years; in millions of dollars)
	2000	2001	2002	2003	2004	2005
Net costs...............	0	15	35	50	65	85

 

6. EXPLANATION OF DIFFERENCES BETWEEN OMB AND CBO ESTIMATES:

Although there are minor differences in the year to year pattern of spending, OMB and CBO estimates are the same over five years.

7. CUMULATIVE EFFECT OF DIRECT SPENDING AND REVENUE LEGISLATION ENACTED TO DATE:

	(Fiscal years; in millions of dollars)
	2000	2001	2002	2003	2004	2005
Outlay effect..............	34	372	1,168	1,298	1,821	1,763
Receipt effect............	-8	-620	-698	-746	-781	-768
Net costs....................	42	992	1,866	2,044	2,602	2,531

NOTE: The cumulative effect of direct spending and revenue legislation enacted to date is currently estimated to result in an end-of-session sequester. The Administration looks forward to working with the Congress to ensure that an unintended sequester does not occur.